Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. Ochiai R, Hayashi K, Yamamoto H, Fujii R, et al. Cancer Sci 2022;113:3960-3971.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ochiai R, Hayashi K, Yamamoto H, Fujii R, et al. Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. Cancer Sci 2022;113:3960-3971.
PMID: 36028467